Ledger.Open graph →
SEC Form D · filed March 19, 2010

Genetix Pharmaceuticals Inc

Offering
$47.4M
Sold
$29.4M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (8)

Nick Leschly · Cambridge, MAExec · DirectorAxel Polack · Cambridge, MADirectorGeert-Jan Mulder · Cambridge, MADirectorJames A. Geraghty · Cambridge, MADirectorDan R. Aton · N. Billerica, MAExec · DirectorGregg G. Brandon · N. Billerica, MADirectorJohn H. Wyant · N. Billerica, MADirectorJames A. Geraghty · LONDON, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗